186 Chapter 7 67. Tazi Mezalek A, Squalli Houssaini Z, Soufiani A, Mouine N, Marza Florensa A, Alami M. Secondary prevention of Coronary Heart Disease (CHD) in the Moroccan population. Survey of Risk Factor (SURF) CHD II Morocco. Eur J Prev Cardiol. 2023 May 24;30(Supplement_1). 68. Gabulova R, Marzà-Florensa A, Rahimov U, Isayeva M, Alasgarli S, Musayeva A, et al. Risk factors in cardiovascular patients: Challenges and opportunities to improve secondary prevention. World J Cardiol. 2023 Jul 26;15(7):342–53. 69. Kotseva K, De Bacquer D, Jennings C, Gyberg V, De Backer G, Rydén L, et al. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999–2013. Glob Heart. 2017;12(4):315-322.e3. 70. Zhao M, Vaartjes I, Klipstein-Grobusch K, Kotseva K, Jennings C, Grobbee DE, et al. Quality assurance and the need to evaluate interventions and audit programme outcomes. Eur J Prev Cardiol. 2017 Jun 16;24(3_suppl):123–8.
RkJQdWJsaXNoZXIy MTk4NDMw